ARCHIVES

Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.”

This article is from The Cancer Letter archive.

Vol. 31 No. 46 | December 16, 2005

Download PDF Visit The Full Archive

Related Articles

In Brief: Senate Sets NCI rescission At $14 Million Baltimore Program Conversation To Cancer Center Will Be asked

May 15, 1981

Schmidt Approve NCAB Authorizations

February 18, 1977

Interview with Christine Berg: ST Findings Relevant Only To High-Risk;

November 26, 2010

Ruffin Sworn In As Director, NIH Minority Health Center.

January 12, 2001

Research Training – On The Road Back, With Trainee Stipends, Payback Feature

June 14, 1974

Three Institutions In Texas To Form Center For Childhood Cancer Epidemiology Research.

February 2, 2001